N-PHENYLACETYL-2-(2-CHLOROPHENYL)-D-GLYCINE, 97.0%, 250mg

6-Bromo-N,N-dimethyl-2-quinazolinamine, 95.0%, 25g

4-Benzyl-1-piperazine-carboxylic acid amidehydrochloride, 98.0%, 2g

Furo[3,4-b]pyrazine-5,7-dione, 97.0%, 5g

tert-Butyl (2-bromophenyl)carbamate, 95.0%, 1g

2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetamide, 95.0%, 1g

2-Nitrophenylsulfenyl Chloride [N-Protecting Agent for Peptides Research]>95.0%(GC)(T)25g

3,3-Difluorohexanoic acid ethyl ester (stabilised over Potassium Carbonate), 5g

2-Chloro-3-methoxybenzonitrile, 97%, 10g

2-(4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)phenyl)acetic acid, 95.0%, 2.5g

4-(4-Bromophenyl)-4-(4-chlorophenyl)piperidine hydrochloride, 96%, 100mg

(9H-Fluoren-9-yl)methyl prop-2-yn-1-ylcarbamate, 97%, 10g

21-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,7,10,13,16,19-hexaoxaheneicosanoic acid, 95%, 1g